Physician profile
Daniel A Diener
NPI 1144214560
$7,797.26
in general payments reported to CMS, 2019-2025
14 companies · $579 in 2025
The $579 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2021: $49.16 · 2022: $2,193 · 2023: $2,585 · 2024: $1,642 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,380 · Food and Beverage: $2,002 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,379.83 |
| Food and Beverage | $2,002.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,226.71 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,538.03 | 2019-2023 | |
| Senseonics, Incorporated | $400.00 | 2025 | Eversense |
| Medline Industries LP | $114.24 | 2019 | |
| Boston Scientific Corporation | $104.01 | 2024-2025 | Axios, Spyglass Discover |
| Kerecis Limited | $103.20 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Covidien LP | $87.70 | 2019 | |
| Smith+Nephew, INC. | $64.86 | 2019 | |
| Derma Sciences, INC. | $39.36 | 2019 | |
| Celularity INC. | $36.00 | 2019 | |
| Davol INC. | $34.67 | 2021 | |
| Reprise Biomedical, INC. | $20.53 | 2025 | Miro3d |
| Ethicon US, LLC | $15.07 | 2023 | Enseal, Echelon; Endopath |
| Organogenesis INC. | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Diener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.